Three Patients with Lithium-Associated Hyperparathyroidism: Literature Review Regarding Medical and Surgical Management
Autor: | Anjay Rastogi, Farid Arman, Marina Barsoum, Ramy M Hanna, Jennifer Han, Michelle D Sangalang, Huma Hasnain, Aarthi Arasu, Avital Harari, Hyunah Poa |
---|---|
Rok vydání: | 2019 |
Předmět: |
Parathyroidectomy
medicine.medical_specialty endocrine system diseases Lithium (medication) medicine.medical_treatment 030232 urology & nephrology Urology Case Report Context (language use) Lithium 030204 cardiovascular system & hematology lcsh:RC870-923 Tertiary hyperparathyroidism Bone resorption 03 medical and health sciences 0302 clinical medicine medicine Hypercalciuria Hyperparathyroidism Calcimimetics business.industry lcsh:Diseases of the genitourinary system. Urology Parathyroid hormone levels medicine.disease Secondary hyperparathyroidism Nephrology Hypercalcemia business medicine.drug |
Zdroj: | Case Reports in Nephrology and Dialysis Case Reports in Nephrology and Dialysis, Vol 9, Iss 2, Pp 108-118 (2019) |
ISSN: | 2296-9705 |
DOI: | 10.1159/000502399 |
Popis: | Lithium (Li) carbonate has been established as a mood stabilizer and an efficacious treatment for bipolar disorder since its discovery by Dr. John Cade in 1948. Li interacts significantly with organ systems and endocrine pathways. One of the most challenging side effects of Li to manage is its effect on the parathyroid glands. Dysregulation of parathyroid signaling due to Li results in hypercalcemia due to increased vitamin D3 generation, increased calcium absorption from the gut, and bone resorption, occasionally resulting in concomitant hypercalciuria. However, hypercalciuria is not a definitive feature for hyperparathyroidism, and normal calcium excretion might be seen in these patients. Hypercalcemia may also result from volume contraction and decreased renal clearance, which are commonly seen in these patients. Anatomically the parathyroid abnormalities can present as single or multiglandular disease. We report 3 cases where the patients developed multiple side effects of Li therapy as well as hypercalcemia due to hyperparathyroidism. The literature is reviewed with regard to medical and surgical management of Li-associated hyperparathyroidism in the context of these 3 presented cases. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |